4 Week, Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The primary purpose of the study is to determine the safety and tolerability of AZD1446 vs
Placebo given as an add-on treatment to Donepezil for 4 weeks in patients with mild to
moderate Alzheimer's disease.